Study shows Samento to be effective
in treating Lyme Borreliosis:
An infection linked to over 300 medical conditions

Control Group: A few patients experienced slight improvement, and the rest remained with no positive change in their clinical condition at the end of the study

Experimental Group: 100% of patients experienced marked clinical improvement; 85% were seronegative for Lyme borreliosis at end of study

Pilot Study Results

A 8-month pilot study was recently conducted with 28 patients suffering from Advanced Chronic Lyme borreliosis. All the patients tested positive for Lyme borreliosis utilizing the Western Blot blood test for Borrelia burgdorferi, the bacteria that causes Lyme disease. The control group was treated with antibiotics, and at the end of the study, from 14 patients in the group,

3 improved slightly, 3 got worse and the rest remained with no change in their clinical condition. The experimental group was treated with Samento (Pentacyclic Alkaloid Chemotype Uncaria tomentosa). At the end of the study 85% of the patients in this group tested negative for Borrelia burgdorferi, and all the patients experienced a dramatic improvement in their clinical condition  A full report will be available soon.

Return to Samento page